TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14556543

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg per day for 8 weeks
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg per day for 8 weeks
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg per day for 8 weeks
Number of subjects: 101
Study: 11524467

Group type: EXPERIMENTAL
Intervention: 0.10 mg/day of 17 beta‐estradiol by skin patch
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 20
Study: 9170199

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (ursodiol)
Number of subjects: 0
Study: 8390287

Group type: EXPERIMENTAL
Intervention: Bolus therapy
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) therapy
Number of subjects: 159

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 159
Study: 3568934

Group type: EXPERIMENTAL
Intervention: Medium-chain triglyceride (MCT)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Long-chain triglyceride (LCT)
Number of subjects: 6
Study: 29855175

Group type: EXPERIMENTAL
Intervention: ABT-122 (120 or 240 mg every week)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: ABT-122 (120 mg every week)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: ABT-122 (240 mg every week)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg every other week)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 27692642

Group type: EXPERIMENTAL
Intervention: 0.25‐1mm particle size (small particles)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1‐2mm particle size (large particles)
Number of subjects: 10
Study: 24629425

Group type: EXPERIMENTAL
Intervention: Afoxolaner (oral chewable formulation at a dose of 2.5mg/kg)
Number of subjects: 16
Study: 22831890

Group type: EXPERIMENTAL
Intervention: Lidocaine/tetracaine patch (Rapydan)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Subcutaneous injection of lidocaine 1%
Number of subjects: 90
Study: 20339141

Group type: EXPERIMENTAL
Intervention: Incentive-based intervention (vouchers for abstaining from smoking)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control condition (vouchers independent of smoking status)
Number of subjects: 158
Study: 19336497

Group type: EXPERIMENTAL
Intervention: 200 mug extra fine hydrofluoroalkane (HFA) beclometasone dipropionate twice daily
Number of subjects: 243

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 243
Study: 16437396

Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET/CT fusion imaging
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional 2-mm thickness whole-body CT scan
Number of subjects: 15
Study: 12897276

Group type: EXPERIMENTAL
Intervention: Office-based educational program
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study: 10506039

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg taken orally three times daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 8671376

Group type: EXPERIMENTAL
Intervention: Interceed applied to one ovary
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control ovary (no Interceed)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Interceed and Control
Number of subjects: 21
Study: 1667755

Group type: EXPERIMENTAL
Intervention: Cyclical transdermal oestradiol 0.05 mg per day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Oral conjugated equine oestrogens 0.625 mg per day
Number of subjects: 45
Study: 7059440

Group type: EXPERIMENTAL
Intervention: New osmotic pressure mediated delivery system for metoprolol (Lopresor Oros)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial slow-release preparation (Slow Lopresor)
Number of subjects: 0
Study: 31626166

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (chondroguard)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Control group (no lower back pain syndrome)
Number of subjects: 315
Study: 28423145

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy (BBT) - 8 to 12 weekly 45-minute sessions delivered by master's-level clinicians.
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy (BBT)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Assisted Referral to Care (ARC)
Number of subjects: 185
Study: 25876224

Group type: EXPERIMENTAL
Intervention: PEMFs application (I-ONE group)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo treatment (placebo group)
Number of subjects: 68
Study: 24165545

Group type: EXPERIMENTAL
Intervention: Standard treatment with adjunctive slow-release dexamethasone implant
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 140
Study: 21378011

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 60
Study: 19056646

Group type: EXPERIMENTAL
Intervention: Green tea extract (714 mg/d GTP), 6 capsules per day for 3 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 17365528

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings (pressure at ankle 18 - 22 mmHg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (ankle-length sports socks only)
Number of subjects: 28
Study: 12648190

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Regional anaesthesia
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: General anaesthesia (excluding patients who did not receive allocated anaesthetic)
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (excluding patients who did not receive allocated anaesthetic)
Number of subjects: 438
Study: 10719615

Group type: EXPERIMENTAL
Intervention: Sustained-release capsule of UDCA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release preparation of UDCA
Number of subjects: 0
Study: 9187172

Group type: EXPERIMENTAL
Intervention: CT-SK (chest tube pleural drainage plus streptokinase)
Number of subjects: 20

Group type: COMPARATOR
Intervention: VATS (video-assisted thoracoscopic surgery)
Number of subjects: 20
Study: 1540063

Group type: EXPERIMENTAL
Intervention: 20 mL of 0.25% bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20 mL of 0.9% saline solution
Number of subjects: 40
Study: 2881428

Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bromazepam and Thioridazine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Psychotherapy and Drug Treatment
Number of subjects: 80
Study: 29608672

Group type: EXPERIMENTAL
Intervention: ACCEPt intervention (multifaceted intervention to increase chlamydia testing)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Quarterly feedback (component of the ACCEPt intervention)
Number of subjects: 44
Study: 30088707

Group type: EXPERIMENTAL
Intervention: Compound amino acid plus vitamin E
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vitamin E only
Number of subjects: 120
Study: 25419768

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (CHG) cloths, used to clean skin 3 times per week for 6 months
Number of subjects: 4196

Group type: COMPARATOR
Intervention: No skin treatment (Control group 3)
Number of subjects: 4196

Group type: COMPARATOR
Intervention: Water cloths (Control group 2)
Number of subjects: 4196

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (CHG) cloths
Number of subjects: 4196
Study: 23181988

Group type: EXPERIMENTAL
Intervention: $20 incremental incentive group (n=30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: $40 incremental incentive group (n=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No incentive control group (n=30)
Number of subjects: 90
Study: 20547650

Group type: EXPERIMENTAL
Intervention: Preventive care program (9 home visits over the first year from a physiotherapist and a psychologist)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preventive care program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study: 18606965

Group type: EXPERIMENTAL
Intervention: Sumatriptan 85 mg and naproxen sodium 500 mg (sumatriptan/naproxen)
Number of subjects: 1111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: Sumatriptan/naproxen
Number of subjects: 1111
Study: 16015049

Group type: EXPERIMENTAL
Intervention: Delayed-release propranolol (INP) dosed at 10 p.m.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Traditionally dosed propranolol (ILA) dosed at 8 a.m.
Number of subjects: 44
Study: 12359798

Group type: EXPERIMENTAL
Intervention: Comprehensive disease management program
Number of subjects: 119
Study: 10554688

Group type: EXPERIMENTAL
Intervention: Specific inspiratory muscle training (SIMT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham training (Control)
Number of subjects: 20
Study: 8918511

Group type: COMPARATOR
Intervention: Diet + Exercise
Number of subjects: 219

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 219

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 219

Group type: COMPARATOR
Intervention: Subgroup analysis (good responders)
Number of subjects: 219
Study: 1683673

Group type: EXPERIMENTAL
Intervention: Amoxicillin trihydrate
Number of subjects: 518

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study: 6791197

Group type: EXPERIMENTAL
Intervention: Ro 11-2465 (1 mg daily for 3 days, then 3 mg daily for 7 days)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ro 11-2465 (after drug withdrawal)
Number of subjects: 6
Study: 31939691

Group type: COMPARATOR
Intervention: Turn-assist technologies (two different turn-assist hospital beds)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manual turning
Number of subjects: 0
Study: 30902690

Group type: EXPERIMENTAL
Intervention: Endotracheal tube (ETI)
Number of subjects: 2652

Group type: COMPARATOR
Intervention: Laryngeal tube (LT)
Number of subjects: 2652

Group type: EXPERIMENTAL
Intervention: Epinephrine administration <10 min from EMS arrival
Number of subjects: 2652

Group type: COMPARATOR
Intervention: Epinephrine administration ≥10 min from EMS arrival
Number of subjects: 2652
Study: 28218589

Group type: EXPERIMENTAL
Intervention: Visual‐perceptual and haptic‐perceptual training program (12 sessions)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional handwriting training
Number of subjects: 28
Study: 25640368

Group type: EXPERIMENTAL
Intervention: Prophylactic use of JiSaiXin (G‐CSF) 150ug per day for three days after chemotherapy (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: G‐CSF (JiSaiXin) after neutropenia (Group B)
Number of subjects: 100
Study: 25138978

Group type: EXPERIMENTAL
Intervention: PROMIS four-item depression scale
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: PROMIS four-item anxiety scale
Number of subjects: 244
Study: 22067789

Group type: EXPERIMENTAL
Intervention: New tablet formulation containing 0.02 mg ethinylestradiol/3 mg drospirenone/0.451 mg levomefolate calcium
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ethinylestradiol/drospirenone tablet
Number of subjects: 44

Group type: COMPARATOR
Intervention: Levomefolate calcium tablet
Number of subjects: 44
Study: 19464609

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 30
Study: 17226060

Group type: EXPERIMENTAL
Intervention: Dorsiflexion pedaling technique
Number of subjects: 11

Group type: COMPARATOR
Intervention: Self-selected control position
Number of subjects: 11
Study: 15224204

Group type: EXPERIMENTAL
Intervention: Interdisciplinary approach offered by the Western Negev Mobile Clinic Diabetes Program (WNMDCP) for 6 months.
Number of subjects: 437

Group type: COMPARATOR
Intervention: Usual treatment in control clinic for 6 months.
Number of subjects: 437
Study: 11796283

Group type: EXPERIMENTAL
Intervention: Mass mail recruitment technique
Number of subjects: 2931

Group type: EXPERIMENTAL
Intervention: Newspaper recruitment technique
Number of subjects: 2931

Group type: EXPERIMENTAL
Intervention: Medical sources recruitment technique
Number of subjects: 2931

Group type: EXPERIMENTAL
Intervention: Radio recruitment technique
Number of subjects: 2931

Group type: EXPERIMENTAL
Intervention: Newsletters recruitment technique
Number of subjects: 2931
Study: 9675505

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CBT) with exposure and response prevention
Number of subjects: 101
Study: 7926899

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Classic needle acupuncture
Number of subjects: 8

Group type: COMPARATOR
Intervention: Laser acupuncture
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 8
Study: 2696997

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg t.i.d. after 7-10 days
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Single dose of 10 mg diazepam after 3-4 hours
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 524315

Group type: EXPERIMENTAL
Intervention: High molecular weight heparin fraction (intravenous injection)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin fraction (intravenous injection)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin fractions (subcutaneous injection)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Intravenous heparin injection (general)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: High molecular weight heparin (general)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (general)
Number of subjects: 5
Study: 31680339

Group type: EXPERIMENTAL
Intervention: Socket-shield technique (SST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional flap-less (control)
Number of subjects: 30
Study: 30825258

Group type: EXPERIMENTAL
Intervention: Data-prompted interviews using the Theoretical Domains Framework (TDF)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Interventions that challenge dysfunctional beliefs about adherence and support the development of routines or habits and problem-solving
Number of subjects: 18
Study: 28558854

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt
Number of subjects: 14

Group type: COMPARATOR
Intervention: Acidified milk
Number of subjects: 14
Study: 26093877

Group type: EXPERIMENTAL
Intervention: Rhythm control (RhC)
Number of subjects: 1391

Group type: COMPARATOR
Intervention: Rate control (RaC)
Number of subjects: 1391
Study: 24216069

Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs at a dose of 3 g/day for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 40
Study: 21345849

Group type: EXPERIMENTAL
Intervention: Neopterin levels measured at study entry
Number of subjects: 3946

Group type: EXPERIMENTAL
Intervention: Neopterin levels added to a multivariable Cox model
Number of subjects: 3946
Study: 18556608

Group type: EXPERIMENTAL
Intervention: Exercise intervention (three 50-minute aerobic sessions each week for 6 months)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 156
Study: 17385181

Group type: EXPERIMENTAL
Intervention: Bipolar coagulating electric vein stripper (EVS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional stripping
Number of subjects: 200
Study: 16648741

Group type: EXPERIMENTAL
Intervention: Spinal stabilization rehabilitation program
Number of subjects: 346

Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 346

Group type: COMPARATOR
Intervention: Minimal intervention control group
Number of subjects: 346
Study: 12859262

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (ISMN), 10 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Timolol maleate (positive control)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (ISMN)
Number of subjects: 10
Study: 10609625

Group type: EXPERIMENTAL
Intervention: Salmeterol added to low-dose beclomethasone dipropionate therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doubling the dose of beclomethasone dipropionate
Number of subjects: 0
Study: 8622048

Group type: EXPERIMENTAL
Intervention: Treatment regimen for black myeloma patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment regimen for white myeloma patients
Number of subjects: 0
Study: 1941055

Group type: EXPERIMENTAL
Intervention: 5FU plus low-dose leucovorin
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: 5FU plus high-dose leucovorin
Number of subjects: 457

Group type: COMPARATOR
Intervention: 5FU plus high-dose MTX with leucovorin rescue
Number of subjects: 457
Study: 6756832

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 95

Group type: COMPARATOR
Intervention: Nasogastric suction
Number of subjects: 95
Study: 28965930

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27164714

Group type: EXPERIMENTAL
Intervention: Rotigotine (1-3 mg/24 h)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 24186673

Group type: EXPERIMENTAL
Intervention: Metal-on-metal total hip arthroplasties (M2a-Magnum, Biomet)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Metal-on-polyethylene total hip arthroplasties (Mallory-Head, Biomet)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups (Metal-on-metal and Metal-on-polyethylene)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Serum metal ion levels (cobalt, chromium, titanium)
Number of subjects: 70
Study: 21733297

Group type: EXPERIMENTAL
Intervention: Richly micronutrient-fortified infant food
Number of subjects: 743
Study: 20399406

Group type: EXPERIMENTAL
Intervention: Yogurt intervention (substitution of part of the WIC milk allowance with yogurt)
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Yogurt intervention
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Yogurt intervention (for those in the lowest tertile of yogurt intake at baseline)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Control group (no yogurt intervention)
Number of subjects: 511
Study: 19078833

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Logistic Regression Model
Number of subjects: 127
Study: 15725351

Group type: EXPERIMENTAL
Intervention: CXCL10 and its receptor CXCR3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IFN-gamma
Number of subjects: 0
Study: 12039927

Group type: EXPERIMENTAL
Intervention: Screening for prostate cancer with PSA testing
Number of subjects: 20716

Group type: COMPARATOR
Intervention: No family history
Number of subjects: 20716

Group type: EXPERIMENTAL
Intervention: Overall screening program
Number of subjects: 20716
Study: 10515178

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 150
Study: 7795939

Group type: EXPERIMENTAL
Intervention: External visual imagery group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Internal visual imagery group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: External visual imagery
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Internal visual imagery
Number of subjects: 24
Study: 2026301

Group type: EXPERIMENTAL
Intervention: Intravesical lidocaine gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral emepronium bromide
Number of subjects: 30
Study: 6779888

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gastrostomy feeding
Number of subjects: 24
Study: 31566164

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 230
Study: 31006684

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (CCT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Mailings
Number of subjects: 97
Study: 28942715

Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray 100 mcg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray 200 mcg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray 400 mcg
Number of subjects: 96

Group type: COMPARATOR
Intervention: Fentanyl citrate intravenous 50 mcg
Number of subjects: 96
Study: 25478944

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 731
Study: 22789309

Group type: EXPERIMENTAL
Intervention: Maximal eccentric exercise of the elbow flexors (60 maximal eccentric elbow flexions)
Number of subjects: 18
Study: 22098690

Group type: EXPERIMENTAL
Intervention: Endoscopic Saphenous harvesting with an Open CO2 System
Number of subjects: 230

Group type: COMPARATOR
Intervention: Conventional vein harvesting
Number of subjects: 230
Study: 19308757

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vibration Threshold (VT) measurements
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Neurological tests and questionnaire
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Follow-up time
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Feet neuropathy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Other determinants (platinum levels, renal function, glutathione transferase genotypes, diabetes mellitus, alcohol use, co-medication)
Number of subjects: 45
Study: 16106400

Group type: EXPERIMENTAL
Intervention: EBV BamH1W assay
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: EBV polymerase assay
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Stage III or IV disease
Number of subjects: 130

Group type: COMPARATOR
Intervention: Community control
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Unaffected family members
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: EBV load test
Number of subjects: 130
Study: 12684919

Group type: EXPERIMENTAL
Intervention: Multivitamins (vitamins B, C, and E)
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Vitamin A (preformed vitamin A and beta carotene)
Number of subjects: 1078
Study: 10919528

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg IM
Number of subjects: 155

Group type: COMPARATOR
Intervention: Meperidine 1 mg/kg IM
Number of subjects: 155